TLSA · Company research
Tiziana Life Sciences Ltd. Common Shares (TLSA): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
17records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| The last patient starts dosing in Tiziana (TLSA)’s Phase 2 Alzheimer’s trial. - Stock Titan | The last patient starts dosing in Tiziana (TLSA)’s Phase 2 Alzheimer’s trial. Stock Titan | View source ↗ | Stock Titan | Oct 16, 2026 | neutral | 0 | 0.6 |
| The final patient has begun dosing in a nasal Alzheimer’s trial testing the drug alone and with two approved treatments. - Stock Titan | The final patient has begun dosing in a nasal Alzheimer’s trial testing the drug alone and with two approved treatments. Stock Titan | View source ↗ | Stock Titan | Oct 16, 2026 | neutral | 0 | 0.6 |
| Tiziana Life Sciences (TLSA) Climbs 5.75% to $1.20 as Shares Push Toward Resistance - Gamma Exposure - https://www.dars.gov.et/ | Tiziana Life Sciences (TLSA) Climbs 5.75% to $1.20 as Shares Push Toward Resistance - Gamma Exposure https://www.dars.gov.et/ | View source ↗ | https://www.dars.gov.et/ | Oct 9, 2026 | neutral | 0 | 0.6 |
| A rare disorder’s median survival is 6–9 years. Tiziana seeks FDA rare-disease designation for its nasal drug. - Stock Titan | A rare disorder’s median survival is 6–9 years. Tiziana seeks FDA rare-disease designation for its nasal drug. Stock Titan | View source ↗ | Stock Titan | Sep 30, 2026 | neutral | 0 | 0.6 |
| Three people with ALS have received their first doses in a trial of a nasal drug. - Stock Titan | Three people with ALS have received their first doses in a trial of a nasal drug. Stock Titan | View source ↗ | Stock Titan | Sep 28, 2026 | neutral | 0 | 0.6 |
| Tiziana Life Sciences Signs Saudi Collaboration MOU for New Multiple Sclerosis Trial - The Globe and Mail | Tiziana Life Sciences Signs Saudi Collaboration MOU for New Multiple Sclerosis Trial The Globe and Mail | View source ↗ | The Globe and Mail | Sep 18, 2026 | neutral | 0 | 0.6 |
| A planned MS trial will test Tiziana’s nasal drug with existing treatment - Stock Titan | A planned MS trial will test Tiziana’s nasal drug with existing treatment Stock Titan | View source ↗ | Stock Titan | Sep 17, 2026 | neutral | 0 | 0.6 |
| Tiziana (TLSA) Up +25.96% — Will the Rally Hold Through Earnings? 2026-09-17 - Seasonality Effect - dars.gov.et | Tiziana (TLSA) Up +25.96% — Will the Rally Hold Through Earnings? 2026-09-17 - Seasonality Effect dars.gov.et | View source ↗ | dars.gov.et | Sep 17, 2026 | neutral | 0 | 0.6 |
| $TLSA stock is up 7% today. Here's what we see in our data. - Quiver Quantitative | $TLSA stock is up 7% today. Here's what we see in our data. Quiver Quantitative | View source ↗ | Quiver Quantitative | Aug 20, 2026 | neutral | 0 | 0.6 |
| Tiziana Life Sciences CEO & Executive Director Acquires 18% More Stock - Simply Wall Street | Tiziana Life Sciences CEO & Executive Director Acquires 18% More Stock Simply Wall Street | View source ↗ | Simply Wall Street | Aug 7, 2026 | neutral | 0 | 0.6 |
| Tiziana Life Sciences Stock (TLSA) Opinions on Clinical Trial Updates - Quiver Quantitative | Tiziana Life Sciences Stock (TLSA) Opinions on Clinical Trial Updates Quiver Quantitative | View source ↗ | Quiver Quantitative | Aug 6, 2026 | neutral | 0 | 0.6 |
| TLSA Forecast — Price Target — Prediction for 2027 - TradingView | TLSA Forecast — Price Target — Prediction for 2027 TradingView | View source ↗ | TradingView | Jun 26, 2026 | neutral | 0 | 0.6 |
| Why Is TLSA Stock Rising Today? - Stocktwits | Why Is TLSA Stock Rising Today? Stocktwits | View source ↗ | Stocktwits | May 21, 2026 | neutral | 0 | 0.6 |
| While insiders own 43% of Tiziana Life Sciences Ltd (NASDAQ:TLSA), individual investors are its largest shareholders with 53% ownership - Yahoo Finance | While insiders own 43% of Tiziana Life Sciences Ltd (NASDAQ:TLSA), individual investors are its largest shareholders with 53% ownership Yahoo Finance | View source ↗ | Yahoo Finance | Feb 9, 2026 | neutral | 0 | 0.6 |
| Tiziana Life Sciences: Foralumab's Intranasal Push Is A Good Moonshot (NASDAQ:TLSA) - Seeking Alpha | Tiziana Life Sciences: Foralumab's Intranasal Push Is A Good Moonshot (NASDAQ:TLSA) Seeking Alpha | View source ↗ | Seeking Alpha | Oct 31, 2025 | neutral | 0 | 0.6 |
| symbol__ Stock Quote Price and Forecast - CNN | symbol__ Stock Quote Price and Forecast CNN | View source ↗ | CNN | Aug 20, 2023 | neutral | 0 | 0.6 |
| Tiziana Life Sciences Ltd (TLSA) Stock Price, News, Quote & History - Yahoo! Finance Canada | Tiziana Life Sciences Ltd (TLSA) Stock Price, News, Quote & History Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Mar 14, 2020 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.